Guess which beaten down ASX share is surging 20% today

Marley Spoon posts earnings.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Marley Spoon AG (ASX: MMM) share price is rallying today. Despite no market-sensitive updates, the company did release its results from the quarter ended 30 June 2022.

At the time of writing, the ASX share is trading 12% higher at 27 cents apiece having blown off an intraday high of 30.5 cents.

Man and woman dance back to back in kitchen.

Image source: Getty Images

Marley Soon share price rallies following quarterly

Key takeouts from the quarter include:

  • Q2 2022 net revenue at $158 million, +35% growth year-over-year
  • H1 2022 net revenue of $308 million, +34% growth year-over-year (+26% growth in constant currency)
  • Global Contribution Margin in Q2 at 27.2%, a 50 basis point improvement over the prior
    corresponding period (PCP)
  • Q2 Operating EBITDA loss of $4.37 million
  • Operating Cash Flow at negative $7.72 million and quarter end cash balance of $42 million
  • On track to deliver full year 2022 guidance

What else happened this quarter for Marley Spoon?

The company says that it successfully executed its "three-pillar growth strategy" during the quarter.

This included investment in growing active subscribers, growing basket size and complementing the meal kit business.

Active subscribers grew 13% in the quarter to 309,000 nearly the same level of growth seen in Q1 2022, whereas basket size grew 23% year on year.

Overall, net revenue for Q2 2022 grew 35% year on year leading to an operating EBITDA loss of around $4.4 million, however the company is on track to deliver its full year guidance.

Management commentary

Speaking on the results, Marley Spoon CEO, Fabian Siegel said:

In the second quarter we continued to see good growth that was driven by the successful execution of all three pillars of our growth strategy. We continue to acquire subscribers at attractive unit economics, we have increased average order volumes by expanding our offering to our customers and revenue from our newly acquired ready-to-heat business, Chefgood, further drives growth of our Australian segment.

While the business is growing healthily, we were also able to keep margins stable year-over-year,
offsetting operational headwinds and inflation.

What's next for Marley Spoon?

Marley Spoon expects further challenges from inflation and supply chain volatility. It reaffirms full-year guidance of "mid-to-high teens YoY net revenue organic growth plus full year contribution from Chefgood; Contribution Margin in-line with 2021 [and]; Operating EBITDA better than [$21 million]".

Marley Spoon is down more than 90% in the past 12 months.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Marley Spoon AG. The Motley Fool Australia has recommended Marley Spoon AG. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.
Earnings Results

NEXTDC share price in focus after record FY26 earnings and strong outlook

The company has a strong FY27 outlook thanks to surging data centre demand.

Read more »

a doctor wearing a white coat with a stethoscope around her neck stares out a window with her hand to the side of her face as though in deep thought.
Healthcare Shares

Clarity Pharmaceuticals FY26 earnings: Revenue jumps, losses widen as clinical pipeline progresses

Clarity Pharmaceuticals reported strong FY26 revenue growth, a wider loss, and progress towards commercialisation of its radiopharmaceutical pipeline.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Clinuvel Pharmaceuticals posts 10th consecutive profit and maintains dividend

Clinuvel Pharmaceuticals reported its tenth straight profit, rising cash reserves, and steady dividend for FY2026.

Read more »

Four happy team members working together in a warehouse.
Earnings Results

Mayfield Group share price jumps 18% after delivering record profit and higher dividend

Investors have responded positively to this results release.

Read more »

Beautiful young couple enjoying in shopping, symbolising passive income.
Earnings Results

Beacon Lighting Group share price jumps 14%: FY26 profit drops despite higher sales

The retailer's revenue was higher but its profits were softer.

Read more »

Group of successful real estate agents standing in building and looking at tablet.
Earnings Results

Waypoint REIT posts distributable earnings growth and confirms FY26 outlook

Waypoint REIT delivered 3.4% DEPS growth and strong leasing results in 1H26, affirming full-year guidance amid a cautious sector outlook.

Read more »

An oil refinery worker checks her laptop computer in front of a backdrop of oil refinery infrastructure.
Earnings Results

Horizon Oil FY26 results: Record production and expanding platform

Here's what the oil producer reported for the year.

Read more »

Businesswoman working with laptop and documents in office, with virtual finance related graphs and charts.
Earnings Results

Omni Bridgeway share price falls after profit drops 89% in FY26

The company's revenue jumped 57% in FY26, but profit fell sharply after a one-off gain last year.

Read more »